HGP 2638
Alternative Names: HGP-2638Latest Information Update: 08 Dec 2023
At a glance
- Originator HitGen
- Class Antineoplastics; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Solid tumours
Most Recent Events
- 24 Aug 2023 Early research in Solid tumours in China (unspecified route) prior to August 2023 (HitGen pipeline, August 2023)